NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for Pharmaceutical Company


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
3M Licenses Vaccine Adjuvants to VaxInnate
2009 NOV 26 ... please visit http://www.vaxinnate.com.Keywords: Health, Biotechnology, Pharmaceutical, Toxicology, Conservation, Ecology, Environment, Technology, 3M.This article ... markets. For more information, visit www.3M.com.3M is a trademark of 3M Company. About VaxInnate VaxInnate is a privately-held biotechnology company in Cranbury, NJ ...
Subject: 3M
Price: $3.00
*
Award-winning Diabetes Documentary to Make World TV Premiere on Sundance Channel on World Diabetes Day
2009 NOV 28 ... and Company, Insulin Dependent Diabetes Mellitus, Pediatrics, Pharmaceutical Business, Pharmaceutical Company, Type 1 Diabetes.This article was prepared by Pediatrics Week editors from ...
Subject: Eli Lilly and Company
Price: $3.00
*
BioSpec Global Solutions Inc., announces the appointment of Richard Howarth as Technical Director
2009 NOV 25 ... (for FDA approval) of viable microbial count (VMC or total bacterial count) in water for pharmaceutical quality assurance process.Having the ability to test water efficiently and ... project by the World Health Organization in Hawaii and by OCETA in India.The company holds worldwide patents on the TOGS 3000 and 9000.NB. This news release ...
Subject: BioSpec Global Solutions Inc.; www.biospecglobal.com
Price: $3.00
*
Connectria Aligns with CCSS to Maintain Peak Performance of Its IBM iSeries Hosting
2009 NOV 25 ... most demanding IBM i environments across many industries including insurance, banking, pharmaceutical and manufacturing. Existing customers that rely on CCSS's feature-rich solutions ... member, and a 3-time IBM PartnerWorld Beacon Award Winner.A privately held company, Connectria has built its business through reinvesting profits and without any debt or ...
Subject: Connectria Corporation
Price: $3.00
*
Covidien Successfully Completes Tender Offer for Shares of Aspect Medical Systems, Inc.
2009 NOV 25 ... more about our business.Keywords: Health, Biotechnology, Medical Devices, Pharmaceutical, Medical Supplies, General Health, Mergers, Acquisitions, Common Stock, Finance, ... be traded on the NASDAQ. ABOUT COVIDIEN Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value ...
Subject: Covidien
Price: $3.00
*
Covidien to Present at Lazard Capital Markets Conference
2009 NOV 25 ... learn more about our business.Keywords: Covidien, Health, Medical Devices, Pharmaceutical, Medical Supplies, Investment, Capital Markets, Finance, Investing.This ... 18, 2009. Coleman Lannum, Vice President, Investor Relations, will represent the Company in a session scheduled at 11:30 a.m. ET.A live audio webcast of the ...
Subject: Covidien
Price: $3.00
*
Elan to Present at Lazard Capital Markets 6th Annual Healthcare Conference
2009 NOV 25 ... http://www.elan.com.Keywords: Elan Corporation, plc, Health, Biotechnology, Pharmaceutical, Investment, Capital Markets, Finance, Investing.This article was prepared ... at the same URL. About Elan Elan Corporation, plc is a neuroscience-based biotechnology company committed to making a difference in the lives of patients and their families by ...
Subject: Elan Corporation, plc
Price: $3.00
*
Flu Shots On the Fly
2009 NOV 28 ... Transport, Air, Health, Travel, Transportation, Other Travel, Infectious Diseases, Pharmaceutical, Other H, Air Travel, Airlines, O Hare Airport, Transportation, Air, Air Travel, ... in Chicago, administers these shots in conjunction with a local medical facility. The company projects they will provide more then 60,000 shots at gateside kiosks in 10 airport sites ...
Subject: Nimlok Chicago
Price: $3.00
*
Helix BioMedix Reports Third Quarter 2009 Financial Results
2009 NOV 28 ... in 2010.Keywords: Health, Biotechnology, Fitness and Nutrition, Pharmaceutical, Economics, Advertising, Finance, Financial, Global Economy, Investing, Investment, ... of approximately $134,000 in non-operating expenses including those associated with the company's outstanding convertible notes payable, a decrease in revenue, and an increase in ...
Subject: Helix BioMedix, Inc.
Price: $3.00
*
Inhibitex Reports Third Quarter 2009 Financial Results
2009 NOV 28 ... Health, Biotechnology, Clinical Trials, Infectious Diseases, Pharmaceutical, Research, Science, Electroni, Analogue, Common Stock, Finance, Financial, Investing, ... announced its financial results for the third quarter ended September 30, 2009. The Company held cash, cash equivalents and short-term investments of $21.1 million at September 30, ...
Subject: Inhibitex, Inc.
Price: $3.00
*
Lannett Reports Fiscal 2010 First-Quarter Financial Results
2009 NOV 25 ... our portfolio," Bedrosian added.Keywords: Lannett Company, Inc., Health, Pharmaceutical, Investment, Finance, Financial, InvestingThis article was prepared by ...
Subject: Lannett Company, Inc.
Price: $3.00
*
Locus Pharmaceuticals Announces Focus on Drug Discovery Collaboration Business, Branded as Ansaris
2009 NOV 26 ... technology. It has entered into several drug discovery collaboration projects with pharmaceutical partners, and built a pipeline of early drug development assets for cancer and ... Locus Pharmaceuticals, a drug company that has developed its own internal and partnered pipeline, focusing on oncology, ...
Subject: Locus Pharmaceuticals
Price: $3.00
*
Neurogen Corporation Announces Third Quarter 2009 Financial Results and Updates Operations
2009 NOV 25 ... its drug development independently and, when advantageous, collaborated with world-class pharmaceutical companies to access additional resources and expertise. Statement Regarding Adjusted ... Neurogen Corporation (NASDAQ: NRGN), a drug development company historically focused on drugs for psychiatric and neurological disorders, announced ...
Subject: Neurogen Corporation
Price: $3.00
*
Research in the area of pediatrics reported from Bristol-Myers Squibb Company
2009 NOV 28 ... Behavior, Aggression, Bristol-Myers Squibb Company Inc., Pharmaceutical Business, Pharmaceutical Company, Aripiprazole, Pharmaceuticals, Drugs, Therapy, Treatment, Psychiatry, Bristol-Myers ...
Subject: Pediatrics
Price: $3.00
*
Right first time: Pioneering new methods of drug manufacture
2009 NOV 29 ... new system proven to work by the Leeds team, working alongside Ana Kwokal from Croatian pharmaceutical company PLIVA, has shown that introducing a self-assembled monolayer - a layer of ...
Subject: University of Leeds
Price: $3.00
*
RiskMetrics Group Recommends Stockholders Vote "FOR" Life Sciences Research/Lion Holdings Merger
2009 NOV 25 ... is a global contract research organization providing product development services to the pharmaceutical, agrochemical and biotechnology industries. LSR brings leading technology and capability ... wide range of chemicals which are essential components of LSR's clients' products. The Company's services are designed to meet the regulatory requirements of governments around the ...
Subject: Life Sciences Research, Inc.
Price: $3.00
*
SDI's Expanded Media Innovations Division Brings HIPAA-Compliant Patient-Level Data to the Media and Advertising Industries
2009 NOV 29 ... data and analytical methods SDI has used to generate hundreds of ROI reports for its pharmaceutical company clients to media companies and advertisers in order to show precise ROI metrics that ...
Subject: SDI
Price: $3.00
*
Sydney Adventist Hospital, New South Wales's largest single-campus private hospital, has chosen MetaVision for its Intensive Care and Coronary Care units
2009 NOV 24 ... Keywords: iMDsoft, Health, Biotechnology, Cardiology, Hospitals, Pharmaceutical, Other Health, Research, Science, Information, Asia, China, Data Management, Data ... Information Systems (CIS) for critical care and the perioperative environment. The company's flagship family of solutions, the MetaVision Suite, was first implemented in 1999. It ...
Subject: iMDsoft
Price: $3.00
*
TARIS Appoints Julie Lekstrom Himes, MD, to CMO Post
2009 NOV 24 ... TARIS Biomedical, a specialty pharmaceutical company pioneering the field of drug-device convergence for targeted therapies, announced the ...
Subject: TARIS Biomedical Inc.
Price: $3.00
*
ZOLL Medical Corporation Announces Annual Results
2009 NOV 24 ... Keywords: ZOLL Medical Corporation, Health, Biotechnology, Hospitals, Medical Devices, Pharmaceutical, Professional Services, Finance, Genera, Data Management, Defense, Finance, Financial, ... its fourth quarter financial results. This conference call will be accessible on the Company's home page at www.zoll.com. Recorded replays of this conference call will be available ...
Subject: ZOLL Medical Corporation
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login